Candriam S.C.A. Grows Stock Holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Candriam S.C.A. lifted its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 7.6% during the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 247,627 shares of the medical equipment provider’s stock after buying an additional 17,401 shares during the quarter. Intuitive Surgical makes up 0.7% of Candriam S.C.A.’s holdings, making the stock its 27th largest holding. Candriam S.C.A.’s holdings in Intuitive Surgical were worth $129,251,000 at the end of the most recent quarter.

A number of other large investors also recently modified their holdings of ISRG. Massachusetts Financial Services Co. MA purchased a new position in shares of Intuitive Surgical during the 3rd quarter valued at $558,807,000. Proficio Capital Partners LLC lifted its stake in shares of Intuitive Surgical by 89,098.8% during the 4th quarter. Proficio Capital Partners LLC now owns 949,967 shares of the medical equipment provider’s stock valued at $495,845,000 after buying an additional 948,902 shares in the last quarter. FMR LLC lifted its stake in Intuitive Surgical by 8.3% in the 3rd quarter. FMR LLC now owns 10,971,085 shares of the medical equipment provider’s stock worth $5,389,765,000 after purchasing an additional 838,793 shares in the last quarter. Raymond James Financial Inc. purchased a new stake in Intuitive Surgical in the 4th quarter worth $313,769,000. Finally, Wilmington Savings Fund Society FSB lifted its stake in Intuitive Surgical by 15,322.2% in the 3rd quarter. Wilmington Savings Fund Society FSB now owns 555,661 shares of the medical equipment provider’s stock worth $272,980,000 after purchasing an additional 552,058 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $568.02 on Thursday. The company has a market capitalization of $202.32 billion, a P/E ratio of 88.61, a P/E/G ratio of 5.85 and a beta of 1.43. The company’s 50-day simple moving average is $571.70 and its two-hundred day simple moving average is $530.90. Intuitive Surgical, Inc. has a one year low of $364.17 and a one year high of $616.00.

Insiders Place Their Bets

In other Intuitive Surgical news, CFO Jamie Samath sold 270 shares of the company’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total value of $145,840.50. Following the transaction, the chief financial officer now directly owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, EVP Myriam Curet sold 408 shares of the company’s stock in a transaction dated Tuesday, February 11th. The stock was sold at an average price of $589.75, for a total transaction of $240,618.00. Following the completion of the transaction, the executive vice president now owns 353 shares in the company, valued at $208,181.75. This represents a 53.61 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 12,598 shares of company stock worth $7,223,467 in the last three months. Corporate insiders own 0.90% of the company’s stock.

Analyst Ratings Changes

ISRG has been the topic of several research analyst reports. Barclays boosted their price target on shares of Intuitive Surgical from $610.00 to $674.00 in a research note on Monday, January 27th. UBS Group boosted their price target on shares of Intuitive Surgical from $500.00 to $560.00 and gave the stock a “neutral” rating in a research note on Monday, January 27th. Raymond James boosted their price target on shares of Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a research note on Friday, January 24th. Morgan Stanley upgraded shares of Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Finally, Wells Fargo & Company upped their target price on shares of Intuitive Surgical from $630.00 to $687.00 and gave the company an “overweight” rating in a research report on Friday, January 24th. One analyst has rated the stock with a sell rating, four have issued a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $613.10.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.